CHINA TOPIX

04/25/2025 03:11:32 pm

Make CT Your Homepage

IMS Health

Pfizer

Pfizer-AstraZeneca Merger Could Face Hurdles With Chinese Antitrust Authorities

The deal between Pfizer and AstraZeneca could face hurdles in China'a antitrust regulators.

Real Time Analytics